PT Lavin

927 citations
12 papers · 700 indexed · h-index 8

Impact in

Papers in

PT Lavin

12 papers receiving 654 citations

Peers

PT Lavin
Comparison fields: 5 of 88
  • Nutrition and Dietetics 310
  • Health Informatics 23
  • Physiology 254
  • Reproductive Medicine 45
  • Surgery 235
Replace Ke Jiang with:
Ke Jiang China
Shiqi Wang China
Servet Altay Türkiye
Bekir Uçan Türkiye
Lu Jia China
Eivind Myhre Norway
David B. Gough United Kingdom
Atakan Yeşıl Türkiye
K. C. H. Fearon United Kingdom
Su-Lin Wang China
PT Lavin relative to Ke Jiang China Ke Jiang's profile →
Citations per field
00.5×7.7×
Ke Jiang · 1×
Citations per year

Countries citing papers authored by PT Lavin

Since Specialization
Citations

This map shows the geographic impact of PT Lavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PT Lavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PT Lavin more than expected).

Fields of papers citing papers by PT Lavin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by PT Lavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PT Lavin. The network helps show where PT Lavin may publish in the future.

Co-authorship network

The 22 scholars most cited alongside PT Lavin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with PT Lavin Line = papers co-authored together PT Lavin links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 201968
2 20121
3
The use of ex vivo-activated memory T cells (autolymphocyte therapy) in the treatment of metastatic renal cell carcinoma: final results from a randomized, controlled, multisite study.
199320
4
Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome.
1992428
5 198928
6 19876
7 19877
8 19866
9
Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma.
198335
10
Phase II trial of doxorubicin therapy for advanced islet cell carcinoma.
198241
11
Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group.
198042
12
Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
197618

About PT Lavin

PT Lavin is a scholar working on Reproductive Medicine, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology, Hepatology and Biotechnology, having authored 12 papers that have together received 700 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Renal cell carcinoma treatment (2 papers), Metastasis and carcinoma case studies (2 papers), Intraperitoneal and Appendiceal Malignancies (2 papers), Gastric Cancer Management and Outcomes (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Retinal and Optic Conditions (1 paper). The work is most often cited by research in Nutrition and Dietetics (310 citations), Health Informatics (23 citations), Physiology (254 citations), Reproductive Medicine (45 citations) and Surgery (235 citations). PT Lavin has collaborated with scholars based in United States. Frequent co-authors include Jian Shou, Jeanette M. Daly, Ernest F. Rosato, Moertel Cg, James C. Folk, Robert G. Hahn, Michael Birch, Douglass Ho, Robert C. Bast and V. R. Zurawski. Their work appears in journals such as International Journal of Gynecology & Obstetrics, Gynecologic Oncology, Cancer Research, PubMed and Yearbook of pediatric endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026